^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
zamtocabtagene autoleucel (MB-CART2019.1)
i
Other names: CD2019-targeting CAR T cells, MB-CART2019.1, Anti-CD2019 CAR T cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Miltenyi Biotec
Drug class:
CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy
Related drugs:
